The Histopathology Core provides a wide spectrum of histology and microscopy services to meet the growing needs of diabetes researchers at Columbia University and affiliated institutions. Over the previous funding cycle, due to ovenwhelming demand for these essential services, the histopathology laboratory (formerly part of the Phenotyping core) and microscopy services (formeriy part of the Genomics core) have been consolidated into a new Histopathology Core. The services of this new core include the high quality basic histological and microscopy services offered in the previous funding cycle, but have been expanded to accommodate the changing and growing needs of DRC users and to incorporate newly developed reagents and technologies. Furthermore, Dr. Sussel, a leader in islet biology and pancreas development was recruited to Columbia University and the Berrie Diabetes Center in 2008 and was enlisted to develop and direct this new core. Since its establishment in 2008, the Histopathology Core has assisted 32 DRC investigators supported by 69 grants and 6 non-DRC investigators on projects that have resulted in 61 papers (29 as primary Core) and/or provided data that helped investigators obtain 14 new grants. It has processed 30,000 samples, cut -300,000 sections and performed 36,000 immunohistochemical stains, nearly 18,000 of which by immunofluorescence. The Core plans to continue to provide advanced histophenotyping capabilities to the thriving Columbia University diabetes research community. To this end, the Core will seamlessly integrated its operation with that of the other DRC Core facilities, to maintain an investigator-oriented approach to service and development, implement and sustain effective business practices, and assist the DRC in its overall mission.

Public Health Relevance

Tissue phenotyping is an essential component of analytical tools to understand, diagnose, and treat diabetes. The purpose of this facility is to ease access to complex, time-consuming, and technically intensive procedures to assist DRC investigators, accelerate discovery, streamline practices, and reduce costs and animal use.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK063608-13
Application #
8840930
Study Section
Special Emphasis Panel (ZDK1-GRB-S)
Project Start
Project End
2016-01-31
Budget Start
2015-02-01
Budget End
2016-01-31
Support Year
13
Fiscal Year
2015
Total Cost
$231,640
Indirect Cost
$86,123
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Proto, Jonathan D; Doran, Amanda C; Subramanian, Manikandan et al. (2018) Hypercholesterolemia induces T cell expansion in humanized immune mice. J Clin Invest 128:2370-2375
Martin Carli, Jayne F; LeDuc, Charles A; Zhang, Yiying et al. (2018) FTO mediates cell-autonomous effects on adipogenesis and adipocyte lipid content by regulating gene expression via 6mA DNA modifications. J Lipid Res 59:1446-1460
Arnes, Luis; Liu, Zhaoqi; Wang, Jiguang et al. (2018) Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma. Gut :
Tamucci, Kirstin A; Namwanje, Maria; Fan, Lihong et al. (2018) The dark side of browning. Protein Cell 9:152-163
Accili, Domenico (2018) Insulin Action Research and the Future of Diabetes Treatment: The 2017 Banting Medal for Scientific Achievement Lecture. Diabetes 67:1701-1709
Ravussin, Yann; Edwin, Ethan; Gallop, Molly et al. (2018) Evidence for a Non-leptin System that Defends against Weight Gain in Overfeeding. Cell Metab 28:289-299.e5
Sui, Lina; Danzl, Nichole; Campbell, Sean R et al. (2018) ?-Cell Replacement in Mice Using Human Type 1 Diabetes Nuclear Transfer Embryonic Stem Cells. Diabetes 67:26-35
Laferrère, Blandine; Pattou, François (2018) Weight-Independent Mechanisms of Glucose Control After Roux-en-Y Gastric Bypass. Front Endocrinol (Lausanne) 9:530
Shah, Ankit; Levesque, Kiarra; Pierini, Esmeralda et al. (2018) Effect of sitagliptin on glucose control in type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery. Diabetes Obes Metab 20:1018-1023
Haeusler, Rebecca A; McGraw, Timothy E; Accili, Domenico (2018) Biochemical and cellular properties of insulin receptor signalling. Nat Rev Mol Cell Biol 19:31-44

Showing the most recent 10 out of 225 publications